The automated cell counter market size has grown strongly in recent years. It will grow from $5.75 billion in 2025 to $6.12 billion in 2026 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to growing reliance on manual cell counting limitations, rising clinical diagnostic testing volumes, increased funding for life science research, expansion of pharmaceutical quality control processes, demand for accurate and repeatable lab results.
The automated cell counter market size is expected to see strong growth in the next few years. It will grow to $7.68 billion in 2030 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to growth in personalized medicine research, increasing automation in clinical laboratories, rising adoption of point of care diagnostics, advancements in cell based assays, expansion of biotech research facilities. Major trends in the forecast period include increasing adoption of automated cell counters in clinical diagnostics, rising demand for high throughput cell analysis in research labs, growing preference for optical based automated cell counting systems, expansion of automated cell counters in biopharmaceutical r&d, rising integration of automated cell counting in routine laboratory workflows.
The increasing adoption of personalized medicine is set to drive the growth of the automated cell counter market. Personalized medicine tailors medical treatments to individual patient characteristics, often considering genetic, environmental, and lifestyle factors. This trend is growing due to advancements in genetic research and technology, enabling more precise treatments based on patients' unique profiles. Automated cell counting plays a vital role in personalized medicine by rapidly and accurately analyzing patient-specific cell populations, aiding in the customization of treatments according to individual cellular profiles. For example, the FDA approved 16 new personalized treatments for rare disease patients in February 2024, a significant increase from the 6 approvals in 2022, as reported by the Personalized Medicine Coalition (PMC). This uptrend in personalized medicine adoption will be a key driver for the automated cell counter market's growth.
Leading companies in the automated cell counter market are concentrating on incorporating intelligent algorithms and machine learning, such as the AI automated cell culture system, to streamline and automate cell growth and scalability processes in biological research and biomanufacturing. An AI-automated cell culture system utilizes artificial intelligence to monitor, manage, and optimize cell growth and maintenance autonomously in laboratory settings. For instance, Molecular Devices LLC introduced the CellXpress.ai automated cell culture system in October 2023, featuring machine learning-powered software that simplifies complex cell culture processes. This system integrates an incubator, liquid handler, and imager to automate feeding and passaging schedules, giving scientists more efficiency and control in the lab.
In August 2023, Cell Microsystems, a US-based biotechnology company, acquired Fluxion Biosciences for an undisclosed amount. This acquisition aims to strengthen Cell Microsystems' capabilities in cellular analysis by incorporating Fluxion Biosciences' advanced patch clamp technology and assay tools. Fluxion Biosciences, also based in the US, specializes in developing automated systems and tools for cell-based assays and electrophysiology.
Major companies operating in the automated cell counter market are Thermo Fisher Scientific Inc., Abbott Laboratories, F.Hoffmann-La Roche Ltd., Danaher Corporation, Merck KGaA, BD Biosciences, GE HealthCare Technologies Inc., Corning Incorporated, Agilent Technologies Inc., Olympus Corporation, Nikon Corporation, PerkinElmer Inc., Sysmex Corporation, Bio-Rad laboratories Inc., HORIBA Ltd, Eppendorf, Tecan Group, Miltenyi Biotec, Luminex Corporation, Molecular Devices LLC, Chemometec A/S, NanoEnTek Inc, Sony Biotechnology Inc., Countstar Inc., Aligned Genetics Inc.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Tariffs have impacted the automated cell counter market by increasing the cost of imported optical components, electronic modules, and precision instruments used in laboratory equipment manufacturing. These higher costs have affected pricing and procurement decisions, particularly for advanced instruments used in pharmaceuticals and research institutes in regions such as north america and asia pacific. Smaller laboratories and academic research centers have been more sensitive to price fluctuations. However, tariffs have also encouraged local manufacturing, regional sourcing of components, and investments in domestic life science instrumentation capabilities, supporting long term supply chain resilience.
The automated cell counter market research report is one of a series of new reports that provides automated cell counter market statistics, including automated cell counter industry global market size, regional shares, competitors with an automated cell counter market share, detailed automated cell counter market segments, market trends and opportunities, and any further data you may need to thrive in the automated cell counter industry. This automated cell counter market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
An automated cell counter is a specialized instrument used in laboratory settings to rapidly and accurately count cells within a biological sample. These instruments employ advanced optical or electronic technologies to automate the cell counting process, eliminating the need for manual counting under a microscope.
The main types of products in an automated cell counter include consumable accessories and instruments. Consumables and accessories in automated cell counting comprise items such as reagents, calibration standards, and disposable slides or microplates, crucial for conducting cell counting procedures accurately and efficiently. These products find applications in various areas such as blood analysis, urine analysis, microbial cell count, cell line viability assessment, and others. End users of automated cell counters include pharmaceutical and biotechnology companies, hospitals, diagnostic laboratories, research institutes, and others.North America was the largest region in the automated cell counter market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated cell counter market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the automated cell counter market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The automated cell counter market consists of revenues earned by entities by providing services such as instrument installation, maintenance, technical support, training programs, cell counting processes and customization options. The market value includes the value of related goods sold by the service provider or included within the service offering. The automated cell counter market also includes sales of flow cytometers, image-based cell counters, electrical impedance Coulter counters, reagents, calibration standards, and disposable slides or microplates. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The automated cell counter market size is expected to see strong growth in the next few years. It will grow to $7.68 billion in 2030 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to growth in personalized medicine research, increasing automation in clinical laboratories, rising adoption of point of care diagnostics, advancements in cell based assays, expansion of biotech research facilities. Major trends in the forecast period include increasing adoption of automated cell counters in clinical diagnostics, rising demand for high throughput cell analysis in research labs, growing preference for optical based automated cell counting systems, expansion of automated cell counters in biopharmaceutical r&d, rising integration of automated cell counting in routine laboratory workflows.
The increasing adoption of personalized medicine is set to drive the growth of the automated cell counter market. Personalized medicine tailors medical treatments to individual patient characteristics, often considering genetic, environmental, and lifestyle factors. This trend is growing due to advancements in genetic research and technology, enabling more precise treatments based on patients' unique profiles. Automated cell counting plays a vital role in personalized medicine by rapidly and accurately analyzing patient-specific cell populations, aiding in the customization of treatments according to individual cellular profiles. For example, the FDA approved 16 new personalized treatments for rare disease patients in February 2024, a significant increase from the 6 approvals in 2022, as reported by the Personalized Medicine Coalition (PMC). This uptrend in personalized medicine adoption will be a key driver for the automated cell counter market's growth.
Leading companies in the automated cell counter market are concentrating on incorporating intelligent algorithms and machine learning, such as the AI automated cell culture system, to streamline and automate cell growth and scalability processes in biological research and biomanufacturing. An AI-automated cell culture system utilizes artificial intelligence to monitor, manage, and optimize cell growth and maintenance autonomously in laboratory settings. For instance, Molecular Devices LLC introduced the CellXpress.ai automated cell culture system in October 2023, featuring machine learning-powered software that simplifies complex cell culture processes. This system integrates an incubator, liquid handler, and imager to automate feeding and passaging schedules, giving scientists more efficiency and control in the lab.
In August 2023, Cell Microsystems, a US-based biotechnology company, acquired Fluxion Biosciences for an undisclosed amount. This acquisition aims to strengthen Cell Microsystems' capabilities in cellular analysis by incorporating Fluxion Biosciences' advanced patch clamp technology and assay tools. Fluxion Biosciences, also based in the US, specializes in developing automated systems and tools for cell-based assays and electrophysiology.
Major companies operating in the automated cell counter market are Thermo Fisher Scientific Inc., Abbott Laboratories, F.Hoffmann-La Roche Ltd., Danaher Corporation, Merck KGaA, BD Biosciences, GE HealthCare Technologies Inc., Corning Incorporated, Agilent Technologies Inc., Olympus Corporation, Nikon Corporation, PerkinElmer Inc., Sysmex Corporation, Bio-Rad laboratories Inc., HORIBA Ltd, Eppendorf, Tecan Group, Miltenyi Biotec, Luminex Corporation, Molecular Devices LLC, Chemometec A/S, NanoEnTek Inc, Sony Biotechnology Inc., Countstar Inc., Aligned Genetics Inc.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Tariffs have impacted the automated cell counter market by increasing the cost of imported optical components, electronic modules, and precision instruments used in laboratory equipment manufacturing. These higher costs have affected pricing and procurement decisions, particularly for advanced instruments used in pharmaceuticals and research institutes in regions such as north america and asia pacific. Smaller laboratories and academic research centers have been more sensitive to price fluctuations. However, tariffs have also encouraged local manufacturing, regional sourcing of components, and investments in domestic life science instrumentation capabilities, supporting long term supply chain resilience.
The automated cell counter market research report is one of a series of new reports that provides automated cell counter market statistics, including automated cell counter industry global market size, regional shares, competitors with an automated cell counter market share, detailed automated cell counter market segments, market trends and opportunities, and any further data you may need to thrive in the automated cell counter industry. This automated cell counter market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
An automated cell counter is a specialized instrument used in laboratory settings to rapidly and accurately count cells within a biological sample. These instruments employ advanced optical or electronic technologies to automate the cell counting process, eliminating the need for manual counting under a microscope.
The main types of products in an automated cell counter include consumable accessories and instruments. Consumables and accessories in automated cell counting comprise items such as reagents, calibration standards, and disposable slides or microplates, crucial for conducting cell counting procedures accurately and efficiently. These products find applications in various areas such as blood analysis, urine analysis, microbial cell count, cell line viability assessment, and others. End users of automated cell counters include pharmaceutical and biotechnology companies, hospitals, diagnostic laboratories, research institutes, and others.North America was the largest region in the automated cell counter market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated cell counter market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the automated cell counter market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The automated cell counter market consists of revenues earned by entities by providing services such as instrument installation, maintenance, technical support, training programs, cell counting processes and customization options. The market value includes the value of related goods sold by the service provider or included within the service offering. The automated cell counter market also includes sales of flow cytometers, image-based cell counters, electrical impedance Coulter counters, reagents, calibration standards, and disposable slides or microplates. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Automated Cell Counter Market Characteristics
3. Automated Cell Counter Market Supply Chain Analysis
4. Global Automated Cell Counter Market Trends and Strategies
5. Automated Cell Counter Market Analysis of End Use Industries
7. Global Automated Cell Counter Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Automated Cell Counter Total Addressable Market (TAM) Analysis for the Market
9. Automated Cell Counter Market Segmentation
10. Automated Cell Counter Market Regional and Country Analysis
11. Asia-Pacific Automated Cell Counter Market
12. China Automated Cell Counter Market
13. India Automated Cell Counter Market
14. Japan Automated Cell Counter Market
15. Australia Automated Cell Counter Market
16. Indonesia Automated Cell Counter Market
17. South Korea Automated Cell Counter Market
18. Taiwan Automated Cell Counter Market
19. South East Asia Automated Cell Counter Market
20. Western Europe Automated Cell Counter Market
21. UK Automated Cell Counter Market
22. Germany Automated Cell Counter Market
23. France Automated Cell Counter Market
24. Italy Automated Cell Counter Market
25. Spain Automated Cell Counter Market
26. Eastern Europe Automated Cell Counter Market
27. Russia Automated Cell Counter Market
28. North America Automated Cell Counter Market
29. USA Automated Cell Counter Market
30. Canada Automated Cell Counter Market
31. South America Automated Cell Counter Market
32. Brazil Automated Cell Counter Market
33. Middle East Automated Cell Counter Market
34. Africa Automated Cell Counter Market
36. Automated Cell Counter Market Competitive Landscape and Company Profiles
37. Automated Cell Counter Market Other Major and Innovative Companies
40. Automated Cell Counter Market High Potential Countries, Segments and Strategies
41. Appendix
Executive Summary
Automated Cell Counter Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses automated cell counter market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for automated cell counter? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The automated cell counter market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:
1) By Product: Consumable Accessories; Instruments2) By Application: Blood Analysis; Urine Analysis; Microbial Cell Count; Cell Line Viability; Other Applications
3) By End User: Pharmaceuticals And Biotechnology Companies; Hospitals; Diagnostics Laboratories; Research Institutes; Other End-Users
Subsegments:
1) By Consumable Accessories: Cell Counting Reagents; Cell Counting Slides; Sample Tubes2) By Instruments: Hemocytometers; Flow Cytometers; Automated Cell Counters (Optical Or Impedance-Based)
Companies Mentioned: Thermo Fisher Scientific Inc.; Abbott Laboratories; F.Hoffmann-La Roche Ltd.; Danaher Corporation; Merck KGaA; BD Biosciences; GE HealthCare Technologies Inc.; Corning Incorporated; Agilent Technologies Inc.; Olympus Corporation; Nikon Corporation; PerkinElmer Inc.; Sysmex Corporation; Bio-Rad laboratories Inc.; HORIBA Ltd; Eppendorf; Tecan Group; Miltenyi Biotec; Luminex Corporation; Molecular Devices LLC; Chemometec A/S; NanoEnTek Inc; Sony Biotechnology Inc.; Countstar Inc.; Aligned Genetics Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Automated Cell Counter market report include:- Thermo Fisher Scientific Inc.
- Abbott Laboratories
- F.Hoffmann-La Roche Ltd.
- Danaher Corporation
- Merck KGaA
- BD Biosciences
- GE HealthCare Technologies Inc.
- Corning Incorporated
- Agilent Technologies Inc.
- Olympus Corporation
- Nikon Corporation
- PerkinElmer Inc.
- Sysmex Corporation
- Bio-Rad laboratories Inc.
- HORIBA Ltd
- Eppendorf
- Tecan Group
- Miltenyi Biotec
- Luminex Corporation
- Molecular Devices LLC
- Chemometec A/S
- NanoEnTek Inc
- Sony Biotechnology Inc.
- Countstar Inc.
- Aligned Genetics Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | January 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 6.12 Billion |
| Forecasted Market Value ( USD | $ 7.68 Billion |
| Compound Annual Growth Rate | 5.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 26 |
